ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Effects of Rosuvastatin on Fibrinolytic System of Human Umbilical Vein Endothelial Cells In Vitro

He Fei*; Zhao Jing; Guo Rong; Liang Ying郑州大学; 1
AMERICAN JOURNAL OF THE MEDICAL SCIENCES2014-10
5阅读
引用收藏
分享

摘要

Background: Besides its lipid-lowering effect, rosuvastatin has an antithrombotic effect, the exact underlying mechanism of which is still unclear. The aim of this study was to investigate the effects of rosuvastatin on the fibrinolytic system, including tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA) with its receptor (u-PAR) and plasminogen activator inhibitor-1 (PAI-1), in vascular endothelial cells exposed to oxidized low-density lipoprotein (oxLDL). Methods: Human umbilical vein endothelial cells (HUVEC) were cultured and divided into 7 groups: control, rosuvastatin alone (10 nM), oxLDL alone (100 mg/L), oxLDL plus rosuvastatin (0.1, 1.0 and 10 nM, respectively) and oxLDL plus rosuvastatin (10 nM) with mevalonate (100 mu M). The lactate dehydrogenase activity and concentrations of t-PA, u-PA, u-PAR and PAI-1 protein in culture medium were measured, whereas the expressions of t-PA, u-PA, u-PAR and PAI-1 mRNA in endothelial cells were detected by real-time polymerase chain reaction at 24 hours after treatment. Results: Compared with the control group, oxLDL caused a significant increase in lactate dehydrogenase activity. It could reduce the expression of t-PA mRNA and protein (P < 0.05) and increase the expression of PAI-1 mRNA and protein (P < 0.05). Rosuvastatin could protect the endothelial cells, improve t-PA production and reduce PAI-1 production (P < 0.05), whether in unstimulated HUVEC or in HUVEC exposed to oxLDL. The effects of rosuvastatin on the fibrinolytic system could be reversed by mevalonate. No significant differences in u-PA and u-PAR production were seen among different groups. Conclusions: Rosuvastatin has protective effects on oxLDL-induced damaged human vascular endothelial cells; its antithrombotic effects may be mediated by the regulation of the fibrinolytic system.

学科与关键词

关键词
RosuvastatinFibrinolysisVascular endothelium
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
AMERICAN JOURNAL OF THE MEDICAL SCIENCES
发表日期
2014-10
卷期
第 348 卷, 第 4 期
页码
319-323
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q2
成果收录
SCI
资助标注
China Scholarship Council [2011841094]; Henan Provincial Medical Scientific Research Fund [2011020012, 201203041]; Henan Provincial Health Technology Innovation Talent Project: Young and Middle-aged Technology Innovation Talent Project, National Natural Science Foundation of China [81070445, 30972790]; Guangdong Natural Science Funds [06020896]; Guangdong Provincial Medical Science Research Funds [A2010021]; Key Scientific Research Project of Henan Education Department [13A320443]; Youth Fund of the First Affiliated Hospital of Zhengzhou University [20110901]

作者

  • H

    He Fei (通讯) (第一作者)

    1

  • Z

    Zhao Jing

    1

查看全部 4 位作者收起作者
  • G

    Guo Rong

    1

  • L

    Liang Ying

    1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417